[1]

Smith TA, Kirkpatrick DR, Smith S, et al. Radioprotective agents to prevent cellular damage due to ionizing radiation[J/OL]. J Transl Med, 2017, 15(1): 232[2020-11-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680756. DOI: 10.1186/s12967-017-1338-x.
[2] Fosgerau K, Hoffmann T.  Peptide therapeutics: current status and future directions[J]. Drug Discov Today, 2015, 20(1): 122-128.   doi: 10.1016/j.drudis.2014.10.003
[3] Angell Y, Holford M, Moos WH.  Building on success: a bright future for peptide therapeutics[J]. Protein Pept Lett, 2018, 25(12): 1044-1050.   doi: 10.2174/0929866525666181114155542
[4] Lau JL, Dunn MK.  Therapeutic peptides: historical perspectives, current development trends, and future directions[J]. Bioorg Med Chem, 2018, 26(10): 2700-2707.   doi: 10.1016/j.bmc.2017.06.052
[5] Burdelya LG, Krivokrysenko VI, Tallant TC, et al.  An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models[J]. Science, 2008, 320(5873): 226-230.   doi: 10.1126/science.1154986
[6] Allen RJ, Mathew B, Rice KG.  PEG-peptide inhibition of scavenger receptor uptake of nanoparticles by the liver[J]. Mol Pharmaceutics, 2018, 15(9): 3881-3891.   doi: 10.1021/acs.molpharmaceut.8b00355
[7]

Bao WK, Holt LJ, Prince RD, et al. Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat[J/OL]. Cardiovasc Diabetol, 2013, 12: 148[2020-11-15]. https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-12-148. DOI: 10.1186/1475-2840-12-148.
[8] Rubin SJS, Tal-Gan Y, Gilon C, et al.  Conversion of protein active regions into peptidomimetic therapeutic leads using backbone cyclization and cycloscan—how to do it yourself[J]. Curr Top Med Chem, 2018, 18(7): 556-565.   doi: 10.2174/1568026618666180518094322
[9] Rádis-Baptista G, Campelo IS, Morlighem JERL, et al.  Cell-penetrating peptides (CPPs): from delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis[J]. J Biotechnol, 2017, 252: 15-26.   doi: 10.1016/j.jbiotec.2017.05.002
[10] Toler J, Deputy S, Zakris E, et al.  Cognitive dysfunction after cranial radiation for a brain tumor[J]. J Pediatr Infect Dis Soc, 2016, 5(1): 96-99.   doi: 10.1093/jpids/piv085
[11] Lu LN, Li ZL, Zuo YH, et al.  Radioprotective activity of glutathione on cognitive ability in X-ray radiated tumor-bearing mice[J]. Neurol Res, 2018, 40(9): 758-766.   doi: 10.1080/01616412.2018.1476080
[12]

Sharma UC, Sonkawade SD, Baird A, et al. Effects of a novel peptide Ac-SDKP in radiation-induced coronary endothelial damage and resting myocardial blood flow[J/OL]. Cardiooncology, 2018, 4: 8[2020-11-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497419. DOI: 10.1186/s40959-018-0034-1.
[13] Hajem N, Chapelle A, Bignon J, et al.  The regulatory role of the tetrapeptide AcSDKP in skin and hair physiology and the prevention of ageing effects in these tissues—a potential cosmetic role[J]. Int J Cosmet Sci, 2013, 35(3): 286-298.   doi: 10.1111/ics.12046
[14]

Daly MJ, Gaidamakova EK, Matrosova VY, et al. Small-molecule antioxidant proteome-shields in Deinococcus radiodurans[J/OL]. PLoS One, 2010, 5(9): e12570[2020-11-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933237. DOI: 10.1371/journal.pone.0012570.
[15] Gaidamakova EK, Myles IA, McDaniel DP, et al.  Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio- protective Mn2+-Peptide complex from Deinococcus[J]. Cell Host Microbe, 2012, 12(1): 117-124.   doi: 10.1016/j.chom.2012.05.011
[16]

Gupta P, Gayen M, Smith JT, et al. MDP: A Deinococcus Mn2+-decapeptide complex protects mice from ionizing radiation[J/OL]. PLoS One, 2016, 11(8): e0160575[2020-11-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976947. DOI: 10.1371/journal.pone.0160575.
[17] Xu Y, Wang S, Shen MQ, et al.  hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesis[J]. Blood, 2014, 123(14): 2250-2260.   doi: 10.1182/blood-2013-09-525402
[18] Long S, Wang GJ, Shen MQ, et al.  dTMP-GH fusion protein therapy improves survival after radiation injury combined with skin-burn trauma in mice[J]. Radiat Res, 2019, 191(4): 360-368.   doi: 10.1667/RR5218.1
[19] Okunieff P, Cornelison T, Mester M, et al.  Mechanism and modification of gastrointestinal soft tissue response to radiation: role of growth factors[J]. Int J Radiat Oncol Biol Phys, 2005, 62(1): 273-278.   doi: 10.1016/j.ijrobp.2005.01.034
[20] Zhang LR, Sun WM, Wang JJ, et al.  Mitigation effect of an FGF-2 peptide on acute gastrointestinal syndrome after high-dose ionizing radiation[J]. Int J Radiat Oncol Biol Phys, 2010, 77(1): 261-268.   doi: 10.1016/j.ijrobp.2009.11.026
[21] Booth C, Booth D, Williamson S, et al.  Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage[J]. Cell Prolif, 2004, 37(6): 385-400.   doi: 10.1111/j.1365-2184.2004.00320.x
[22]

Demori I, El Rashed Z, Corradino V, et al. Peptides for skin protection and healing in amphibians[J/OL]. Molecules, 2019, 24(2): 347[2020-11-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359409. DOI: 10.3390/molecules24020347.
[23] Zhang SY, Wang WJ, Peng Y, et al.  Amelioration of radiation-induced skin injury by HIV-TAT-mediated protein transduction of RP-1 from Rana pleurade[J]. Int J Med Sci, 2014, 11(1): 44-51.   doi: 10.7150/ijms.7463
[24] Lee SW, Moon SY, Kim YH, et al.  The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer[J]. Int Wound J, 2007, 4(3): 216-220.   doi: 10.1111/j.1742-481X.2007.00332.x
[25] Ryu SH, Kim YH, Lee SW, et al.  The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis[J]. J Radiat Res, 2010, 51(5): 511-517.   doi: 10.1269/jrr.10010
[26] Bernhardt SL, Gjertsen MK, Trachsel S, et al.  Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase Ⅰ/Ⅱ study[J]. Br J Cancer, 2006, 95(11): 1474-1482.   doi: 10.1038/sj.bjc.6603437
[27]

Park JK, Kim Y, Kim H, et al. The anti-fibrotic effect of GV1001 combined with gemcitabine on treatment of pancreatic ductal adenocarcinoma[J/OL]. Oncotarget, 2016, 7(46): 75081−75093[2020-11-15]. http://www.oncotarget.com. DOI: 10.18632/oncotarget.12057.
[28] Chen W, Shin KH, Kim S, et al.  hTERT peptide fragment GV1001 demonstrates radioprotective and antifibrotic effects through suppression of TGF-β signaling[J]. Int J Mol Med, 2018, 41(6): 3211-3220.   doi: 10.3892/ijmm.2018.3566
[29]

Holler M, Grottke A, Mueck K, et al. Dual targeting of Akt and mTORC1 impairs repair of DNA double-strand breaks and increases radiation sensitivity of human tumor cells[J/OL]. PLoS One, 2016, 11(5): e0154745[2020-11-15]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854483. DOI: 10.1371/journal.pone.0154745.
[30] 李亚楠, 邹炯, 宋璐瑶, 等.  胶原三肽生物活性及其应用研究进展[J]. 食品工业科技, 2018, 39(3): 333-337.   doi: 10.13386/j.issn1002-0306.2018.03.064
Li YN, Zou J, Song LY, et al.  Bioactivities and applications of collagen tripeptides: a review[J]. Sci Technol Food Ind, 2018, 39(3): 333-337.   doi: 10.13386/j.issn1002-0306.2018.03.064
[31] Pollard JD, Quan S, Kang T, et al.  Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts[J]. Arch Facial Plast Surg, 2005, 7(1): 27-31.   doi: 10.1001/archfaci.7.1.27
[32] He LX, Wang JB, Sun B, et al.  Suppression of TNF-α and free radicals reduces systematic inflammatory and metabolic disorders: radioprotective effects of ginseng oligopeptides on intestinal barrier function and antioxidant defense[J]. J Nutr Biochem, 2017, 40: 53-61.   doi: 10.1016/j.jnutbio.2016.09.019